Vanguard Group Inc Nuvectis Pharma, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 298,800 shares of NVCT stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
298,800
Previous 294,283
1.53%
Holding current value
$1.85 Million
Previous $2.45 Million
0.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NVCT
# of Institutions
39Shares Held
2.11MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.48 Million5.37% of portfolio
-
Black Rock Inc. New York, NY373KShares$2.3 Million0.0% of portfolio
-
Baldwin Brothers LLC154KShares$952,5230.1% of portfolio
-
Geode Capital Management, LLC Boston, MA135KShares$831,3830.0% of portfolio
-
State Street Corp Boston, MA129KShares$799,5620.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $90.5M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...